Mesothelioma Trials: OSI-930

Please note: This 2009 clinical trial profile is provided for informational purposes only. In order to obtain more details about this trial, contact the participating healthcare facilities listed at the bottom of this page.

If you are looking for an attorney because you or a loved one has been diagnosed with mesothelioma, asbestos-related lung cancer or asbestosis, our law firm can help. Please fill out the form on this page for a FREE review of your asbestos case.

OSI Pharmaceuticals is currently recruiting patients with mesothelioma and other cancers to participate in a clinical trial of an experimental drug known as OSI-930.

The purpose of the Phase I trial is to determine the tolerability of the drug and evaluate OSI-930’s effectiveness in treating cancer tumors.

The study is being conducted at the H. Lee Moffitt Cancer Center and Research Institute in Tampa, Florida. In addition, the drug is being studied at a hospital in Glasgow, Scotland. For more information, contact the OSI Pharmaceuticals information line at 1 (800) 572-1932.

Weitz & Luxenberg is a leading plaintiffs' law firm that has represented people affected by mesothelioma for over 20 years. Men and women diagnosed with mesothelioma caused by asbestos exposure may be entitled to compensation from the companies responsible for their disease.

If you would like a free consultation or more information about your legal options, please complete the form below, and a representative of our law firm will contact you as soon as possible.